In vitro activation of low-grade non-Hodgkin's lymphoma by murine fibroblasts, IL-4, anti-CD40 antibodies and the soluble CD40 ligand

Leukemia

Volumn 11, Issue 11, 1997, Pages 1862-1867

  Buske, C ^a   Twiling, A ^a   Gogowski, G ^a   Schreiber, K ^a   Feuring Buske, M ^a   Wulf, C G ^a   Hiddemann, W ^a   Wormann B ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Apoptosis; B NHL; Fibroblasts; IL 4

Indexed keywords

CD40 ANTIGEN; GLYCOPROTEIN GP 39; INTERLEUKIN 4; MONOCLONAL ANTIBODY; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CANCER GRADING; CELL SURVIVAL; CELL VIABILITY; CLINICAL ARTICLE; COCULTURE; FIBROBLAST; FOLLICULAR LYMPHOMA; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOCYTOMA; LYMPHOMA CELL; MOUSE; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030657010     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400822     Document Type: Article

References (14)

1. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary M, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Müller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-1392.
2. Tsujimoto Y, Croce CM. Analysis of the structure, transcripts, and protein products of the bcl-2, the gene involved in the follicular lymphoma. Proc Natl Acad Sci USA 1986; 83: 5214-5218.
3. Korsmeyer SJ. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992; 80: 879-886.
4. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 1993; 74: 609-619.
5. Offit K, Parsa NZ, Fillipa D, Jhanwar SC, Chaganti RSK. t(9;14)(p13;q32) denotes a subset of low-grade non-Hodgkin's lymphoma with plasmacytoid differentiation. Blood 1992; 80: 2594-2599.
6. Ford RJ, Kouttab NM, Sahasrabuddhe CG, Davies FM, Mehta SR. Growth factor-mediated proliferation in B cell non-Hodgkin's lymphomas. Blood 1985; 65: 1335-1341.
7. Ambrus JL, Pippin JJ, Joseph A, Chenguang X, Blumenthal D, Tamayo A, Claypool A, McCourt D, Srikiatchatochorn A, Ford RJ. Identification of a cDNA for human high-molecular weight B cell growth factor. Proc Natl Sci USA 1993; 90: 6330-6334.
8. Karray S, Defrance T, Merle-Beral H, Banchereau P, Debre P, Galanaud P. Interleukin 4 counteracts the interleukin 2-induced proliferation of monoclonal B cells. J Exp Med 1988; 168: 85-94.
9. Umetsu D, Essermann L, Donlon TA, DeKruyff RH, Levy R. Induction of proliferation of human follicular (B-type) lymphoma cells by cognate interaction with CD4+ T cell clones. J Immunol 1990; 144: 2550-2557.
10. Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford KN, Macduff BM, Anderson DM, Gimpel SD, Davis-Smith T, Maliszewski CR, Clark EA, Smith CA, Grabstein KH, Cosman D, Spriggs MK. Molecular and biological characterization of murine ligand for CD40. Nature 1992; 357: 80-82.
11. Spriggs MK, Armitage RJ, Strockbine L, Clifford KN, Macduff BM, Sato TA, Maliszewski CR, Fanslow WC. Recombinant human CD40 ligand stimulates B cell proliferation and IgE secretion. J Exp Med 1992; 176: 1543-1550.
12. Durie FH, Foy TM, Masters SR, Laman JD, Noelle RJ. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol Today 1994; 15: 406-410.
13. Arpin C, Dechanet J, Van Kooten C, Merville P, Grouard G, Briere F, Banchereau J, Liu Y-J. Generation of memory B cells and plasma cells in vitro. Science 1995; 268: 720-722.
14. Liu YI, Mason DJ, Johnson CD, Abbot S, Gregory CD, Hardie DL, Gordon J, MacLennan IC. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 1991; 21: 1905-1910.